Churchill Pharmaceuticals has expanded its Commercial Leadership Team to direct more attention to the planning and market analysis necessary for launching its lead portfolio project of TONSATM, meant to treat metastatic castration resistant prostate cancer.
Ben Steinmetz joined the team in 2015 as the senior vice president, commercial, with 30 years of experience from the pharmaceutical and biotech industries.
"As a group, they bring the broad range of critical skills and capabilities needed for commercialization," Steinmetz said.
Sharlene Cirillo, who now is Churchill's vice president, marketing, also has 30 years of experience in domestic marketing, R&D, oncology global and more.
Matt Battin, vice president, sales, has been in the industry for 30 years.
Jim Datz, vice president, market access, has worked in account management throughout his 30 years in the industry.
Frank Barrett, who has been working in the pharmaceutical and biotech markets for 25 years, now comes alongside of Churchill with his experience.
Nate Ide, who is now at Churchill as head of trade and distribution, has worked in a number of companies over his 20 years in the workforce.